Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new laboratory that will certify and ...
USP is collaborating with Phlow to build a new lab that will develop test methods and standards to facilitate broader adoption of continuous manufacturing. The United States Pharmacopeia (USP) and ...
ROCKVILLE, Md., Dec. 12, 2022 /PRNewswire/ -- The U.S. Pharmacopeia (USP) today announced the opening of the USP Advanced Manufacturing Technology Lab in Richmond, Virginia as part of its launch of a ...
In biopharmaceutical manufacturing, consistency is vital but hard to achieve. Turning raw materials into safe, high-quality medicines requires stable processes. However, the living cellular expression ...
Requirements for virus filtration must be considered in developing continuous downstream processes. Bioprocessing technologies have evolved rapidly and significantly during the three decades the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results